Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
74.7M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$863M
-
Value change
-
-$1.8M
-
Put/Call ratio
-
0.02
-
Number of buys
-
73
-
Number of sells
-
-52
-
Price
-
$11.56
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q4 2022
154 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value as of Q4 2022.
Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.7M shares
of 160M outstanding shares and own 46.56% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6M shares), BlackRock Inc. (4.95M shares), COMMODORE CAPITAL LP (4.32M shares), STATE STREET CORP (4.26M shares), VR Adviser, LLC (4.04M shares), TCG Crossover Management, LLC (3.63M shares), VANGUARD GROUP INC (3.47M shares), PERCEPTIVE ADVISORS LLC (3.21M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.97M shares), and Fairmount Funds Management LLC (2.76M shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.